This Week in PLoS Medicine: Pregnancy in DART trial; Health & pharmaceutical R&D

Bookmark and Share

Image Credit: lilivanili

Three new articled published this week in PLoS Medicine, including two magazine pieces on R&D:

Diana Gibb and colleagues investigate the effect of in utero tenofovir exposure by analysing the pregnancy and infant outcomes of HIV-infected women enrolled in the DART trial.

As part of a cluster of articles leading up to the 2012 World Health Report and critically reflecting on the theme of “no health without research,” Suerie Moon and colleagues argue for a global health R&D treaty to improve innovation in new medicines and strengthening affordability, sustainable financing, efficiency in innovation, and equitable health-centered governance.

John-Arne Røttingen and Claudia Chamas, chairs of the the Consultative Expert Working Group on Research and Development (CEWG), summarize their recent report recommending to the World Health Assembly that a global health R&D convention be developed.

Remember you can comment on, annotate and rate any PLoS Medicine article and see the views, citations and other indications of impact of an article on that articles metrics tab.

Related Posts Plugin for WordPress, Blogger...

Creative Commons License
The This Week in PLoS Medicine: Pregnancy in DART trial; Health & pharmaceutical R&D by PLOS Blogs Network, unless otherwise expressly stated, is licensed under a Creative Commons Attribution 4.0 International License.

This entry was posted in PLoS Medicine Week by Week and tagged , , , , , , , . Bookmark the permalink.

Comments are closed.